References
- Grattan C, Powell S, Humphreys F: Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001;144:708–714.
- Hide M, Furue M, Ikezawa Z, Shiohara T, Furukawa F, Matsunaga K, Guidelines for the diagnosis and treatment of urticaria and angioedema (in Japanese). Jpn J Dermatol 2005;115:703–715.
- Okubo Y, Natsume S, Usui K, Amaya M, Tsuboi R. Low-dose, short-term ciclosporin (Neoral(®) ) therapy is effective in improving patients' quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients. Jpn J Dermatol 2011;38:465–472.
- Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren MM. The Japanese version of Skindex-16: A brief quality-of-life measure for patients with skin diseases. J Dermatol 2002;29:693–698.
- Hide M. Urticaria, not mediated by ordinary histamine (in Japanese). Jpn J Clin Dermatol 2003; 57:40–44.
- Kameyoshi Y, Tanaka T, Mihara S, Takahagi, Niimi N, Hide M. Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol 2007;157:803–804.
- Yoshida H, Okawara A, Ishibashi Y, Harada S, Imamura S, Yamamoto S, Dose finding study of cetirizine on chronic urticaria (in Japanese). Clin Rep 1994;28:2107–2129.
- Rihoux JP, Ghys L, Coulie P. Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and Loratadine. Ann Allergy 1990;65:139–142.
- Yosipovitch G, Ansari N, Goon A, Chan YH, Goh CL. Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 2002;147:32–36.